Search

Search Results
Results 51 - 60 of 359 for Anti-aging"
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 31 Mar 2023
    Consumer Medicine Information (CMI) about Viramune XR intended for persons living in Australia.
  • Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Pyralin EN intended for persons living in Australia.
  • Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Drug - 6 Feb 2023
    Consumer Medicine Information (CMI) about Salpraz (pantoprazole) intended for persons living in Australia.
  • Drug - 14 Oct 2022
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Viatris (tenofovir disoproxil maleate 300 mg) intended for persons living in Australia.
  • Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Glyxambi (empagliflozin and linagliptin) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.